FER1L6
geneOn this page
Also known as C8ORFK23
Summary
FER1L6 (fer-1 like family member 6, HGNC:28065) is a protein-coding gene on chromosome 8q24.13, encoding Fer-1-like protein 6 (Q2WGJ9). Calcium/phospholipid-binding protein which is essential for proper development of skeletal and cardiac muscle.
Predicted to enable metal ion binding activity. Predicted to be involved in positive regulation of gene expression. Predicted to act upstream of or within response to bacterium. Predicted to be located in membrane.
Source: NCBI Gene 654463 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 287 total
- MANE Select transcript:
NM_001039112
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28065 |
| Approved symbol | FER1L6 |
| Name | fer-1 like family member 6 |
| Location | 8q24.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | C8ORFK23 |
| Ensembl gene | ENSG00000214814 |
| Ensembl biotype | protein_coding |
| OMIM | 620884 |
| Entrez | 654463 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000522917
RefSeq mRNA: 1 — MANE Select: NM_001039112
NM_001039112
CCDS: CCDS43767
Canonical transcript exons
ENST00000522917 — 41 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001536004 | 124119607 | 124120061 |
| ENSE00001536005 | 124118844 | 124118944 |
| ENSE00001536009 | 124103146 | 124103309 |
| ENSE00001536013 | 124101097 | 124101338 |
| ENSE00001536017 | 124097785 | 124097883 |
| ENSE00001536019 | 124097271 | 124097359 |
| ENSE00001536021 | 124094896 | 124095038 |
| ENSE00001536023 | 124091423 | 124091583 |
| ENSE00001536025 | 124082288 | 124082458 |
| ENSE00001536027 | 124076198 | 124076325 |
| ENSE00001536028 | 124071506 | 124071631 |
| ENSE00001536031 | 124070467 | 124070598 |
| ENSE00001536034 | 124069360 | 124069475 |
| ENSE00001536037 | 124067767 | 124067806 |
| ENSE00001536039 | 124066428 | 124066550 |
| ENSE00001536042 | 124064347 | 124064573 |
| ENSE00001536043 | 124061852 | 124062032 |
| ENSE00001536050 | 124060548 | 124060709 |
| ENSE00001536054 | 124060180 | 124060290 |
| ENSE00001536058 | 124049607 | 124049756 |
| ENSE00001536063 | 124045767 | 124045901 |
| ENSE00001536066 | 124039882 | 124040006 |
| ENSE00001536069 | 124035277 | 124035454 |
| ENSE00001536072 | 124023444 | 124023596 |
| ENSE00001536074 | 124021550 | 124021669 |
| ENSE00001536078 | 124017628 | 124017718 |
| ENSE00001536079 | 124013431 | 124013531 |
| ENSE00001536083 | 124010594 | 124010714 |
| ENSE00001536087 | 124003167 | 124003347 |
| ENSE00001536094 | 123986068 | 123986176 |
| ENSE00001536099 | 123980465 | 123980811 |
| ENSE00001536107 | 123977417 | 123977609 |
| ENSE00001536109 | 123975898 | 123976084 |
| ENSE00001536110 | 123975150 | 123975306 |
| ENSE00001536115 | 123973434 | 123973512 |
| ENSE00001536116 | 123970035 | 123970097 |
| ENSE00001536117 | 123966159 | 123966290 |
| ENSE00001536121 | 123966007 | 123966061 |
| ENSE00001536122 | 123963278 | 123963398 |
| ENSE00002120426 | 123851987 | 123852185 |
| ENSE00002139439 | 123955992 | 123956074 |
Expression profiles
Bgee: expression breadth broad, 65 present calls, max score 77.91.
Top tissues by expression
127 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| rectum | UBERON:0001052 | 77.91 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 72.73 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 72.17 | silver quality |
| duodenum | UBERON:0002114 | 70.11 | gold quality |
| stomach | UBERON:0000945 | 64.47 | gold quality |
| mucosa of stomach | UBERON:0001199 | 62.80 | gold quality |
| body of stomach | UBERON:0001161 | 62.65 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 58.74 | gold quality |
| small intestine | UBERON:0002108 | 58.29 | gold quality |
| transverse colon | UBERON:0001157 | 57.76 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 57.11 | gold quality |
| colonic epithelium | UBERON:0000397 | 56.45 | silver quality |
| adult mammalian kidney | UBERON:0000082 | 55.13 | gold quality |
| kidney | UBERON:0002113 | 54.60 | gold quality |
| stromal cell of endometrium | CL:0002255 | 54.35 | gold quality |
| testis | UBERON:0000473 | 54.13 | gold quality |
| left testis | UBERON:0004533 | 53.41 | gold quality |
| fundus of stomach | UBERON:0001160 | 53.35 | gold quality |
| right testis | UBERON:0004534 | 52.88 | gold quality |
| islet of Langerhans | UBERON:0000006 | 52.18 | gold quality |
| intestine | UBERON:0000160 | 51.57 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 50.42 | gold quality |
| vermiform appendix | UBERON:0001154 | 50.31 | gold quality |
| right uterine tube | UBERON:0001302 | 49.84 | gold quality |
| cortex of kidney | UBERON:0001225 | 49.77 | gold quality |
| colon | UBERON:0001155 | 48.33 | gold quality |
| muscle tissue | UBERON:0002385 | 48.29 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 48.24 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 46.32 | gold quality |
| thyroid gland | UBERON:0002046 | 45.18 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.17 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
19 targeting FER1L6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-6856-5P | 100.00 | 65.47 | 1298 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-1236-3P | 99.94 | 68.04 | 1695 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-6515-3P | 99.82 | 68.19 | 1933 |
| HSA-MIR-510-3P | 99.54 | 70.06 | 2965 |
| HSA-MIR-7106-5P | 99.53 | 67.47 | 3574 |
| HSA-MIR-6081 | 99.48 | 66.07 | 1446 |
| HSA-MIR-3612 | 99.45 | 66.02 | 1333 |
| HSA-MIR-650 | 99.45 | 65.77 | 1309 |
| HSA-MIR-7854-3P | 99.08 | 66.26 | 1117 |
| HSA-MIR-3154 | 98.94 | 66.55 | 1455 |
| HSA-MIR-1304-5P | 98.90 | 68.58 | 1054 |
| HSA-MIR-12120 | 98.05 | 68.44 | 1768 |
| HSA-MIR-4443 | 98.02 | 66.25 | 1928 |
| HSA-MIR-33B-3P | 97.92 | 67.39 | 529 |
| HSA-MIR-515-3P | 97.92 | 67.98 | 506 |
| HSA-MIR-519E-3P | 97.92 | 68.25 | 508 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | fer1l6 | ENSDARG00000019316 |
| mus_musculus | Fer1l6 | ENSMUSG00000037106 |
| rattus_norvegicus | Fer1l6 | ENSRNOG00000025300 |
| drosophila_melanogaster | mfr | FBGN0266757 |
Paralogs (4): OTOF (ENSG00000115155), DYSF (ENSG00000135636), MYOF (ENSG00000138119), FER1L5 (ENSG00000249715)
Protein
Protein identifiers
Fer-1-like protein 6 — Q2WGJ9 (reviewed: Q2WGJ9)
All UniProt accessions (1): Q2WGJ9
UniProt curated annotations — full annotation on UniProt →
Function. Calcium/phospholipid-binding protein which is essential for proper development of skeletal and cardiac muscle.
Subunit / interactions. Interacts with STX4 and VCL.
Subcellular location. Cell membrane. Cytoplasm. Perinuclear region. Golgi apparatus. trans-Golgi network. Recycling endosome.
Domain organisation. The C2 domain associates with lipid membranes in a calcium-dependent manner.
Similarity. Belongs to the ferlin family.
RefSeq proteins (1): NP_001034201* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000008 | C2_dom | Domain |
| IPR012561 | Ferlin_B-domain | Domain |
| IPR012968 | FerIin_dom | Domain |
| IPR032362 | Ferlin_C | Domain |
| IPR035892 | C2_domain_sf | Homologous_superfamily |
| IPR037720 | C2B_Ferlin | Domain |
| IPR037721 | Ferlin | Family |
| IPR037722 | C2C_Ferlin | Domain |
| IPR037723 | C2D_Ferlin | Domain |
| IPR037724 | C2E_Ferlin | Domain |
| IPR037725 | C2F_Ferlin | Domain |
| IPR055072 | Ferlin_DSRM | Domain |
Pfam: PF00168, PF08150, PF08151, PF16165, PF22901
UniProt features (36 total): binding site 12, compositionally biased region 7, domain 6, region of interest 5, topological domain 2, chain 1, transmembrane region 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q2WGJ9-F1 | 76.78 | 0.39 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (12): 842; 848; 904; 906; 1372; 1372; 1378; 1427; 1427; 1429; 1429; 1435
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 38 (showing top):
GOBP_MUSCLE_TISSUE_DEVELOPMENT, GOCC_TRANS_GOLGI_NETWORK, GOBP_MUSCLE_STRUCTURE_DEVELOPMENT, GOBP_SKELETAL_MUSCLE_ORGAN_DEVELOPMENT, GOBP_CIRCULATORY_SYSTEM_DEVELOPMENT, GOCC_RECYCLING_ENDOSOME, GOCC_ORGANELLE_SUBCOMPARTMENT, NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON, GOBP_RESPONSE_TO_BACTERIUM, GOMF_LIPID_BINDING, GOMF_PHOSPHOLIPID_BINDING, GOMF_CALCIUM_DEPENDENT_PHOSPHOLIPID_BINDING, WIERENGA_PML_INTERACTOME, chr8q24, MIR6515_3P
GO Biological Process (4): skeletal muscle tissue development (GO:0007519), response to bacterium (GO:0009617), positive regulation of gene expression (GO:0010628), cardiac muscle tissue development (GO:0048738)
GO Molecular Function (2): calcium-dependent phospholipid binding (GO:0005544), metal ion binding (GO:0046872)
GO Cellular Component (5): trans-Golgi network (GO:0005802), plasma membrane (GO:0005886), perinuclear region of cytoplasm (GO:0048471), recycling endosome (GO:0055037), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| striated muscle tissue development | 2 |
| cellular anatomical structure | 2 |
| skeletal muscle organ development | 1 |
| response to other organism | 1 |
| gene expression | 1 |
| regulation of gene expression | 1 |
| positive regulation of macromolecule biosynthetic process | 1 |
| heart development | 1 |
| phospholipid binding | 1 |
| cation binding | 1 |
| Golgi apparatus subcompartment | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cytoplasm | 1 |
| endosome | 1 |
Protein interactions and networks
STRING
572 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FER1L6 | MEIG1 | Q5JSS6 | 580 |
| FER1L6 | EMG1 | Q92979 | 474 |
| FER1L6 | PLEKHG7 | Q6ZR37 | 462 |
| FER1L6 | FAM186A | A6NE01 | 448 |
| FER1L6 | IMMP2L | Q96T52 | 425 |
| FER1L6 | GOLGA6L2 | Q8N9W4 | 419 |
| FER1L6 | OR2A14 | Q96R47 | 393 |
| FER1L6 | SYCE1 | Q8N0S2 | 369 |
| FER1L6 | EHD2 | Q9NZN4 | 360 |
| FER1L6 | CLRN3 | Q8NCR9 | 356 |
| FER1L6 | CCSAP | Q6IQ19 | 352 |
| FER1L6 | SRRM4 | A7MD48 | 348 |
| FER1L6 | STOX1 | Q6ZVD7 | 348 |
| FER1L6 | GLRX5 | Q86SX6 | 348 |
| FER1L6 | CLCA2 | Q9UQC9 | 348 |
| FER1L6 | ADGRV1 | Q8WXG9 | 348 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FER1L6 | CKMT2 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (10): FER1L6 (Proximity Label-MS), FER1L6 (Proximity Label-MS), FER1L6 (Reconstituted Complex), FER1L6 (Cross-Linking-MS (XL-MS)), FER1L6 (Cross-Linking-MS (XL-MS)), FER1L6 (Cross-Linking-MS (XL-MS)), FER1L6 (Cross-Linking-MS (XL-MS)), HDAC2 (Cross-Linking-MS (XL-MS)), PXDNL (Cross-Linking-MS (XL-MS)), MIF (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0AVI2, A0FGR9, A3KGK3, A6NCM1, A6QQP7, B0DOB4, B3DLH6, B7FF09, B7ZC32, D3ZGS3, F1S5L4, O00329, O35904, O70145, O75923, P0DM40, P32019, P58069, P97564, Q0VA04, Q15283, Q17I16, Q1LXZ7, Q2WGJ9, Q32PH0, Q5DTI8, Q5GJ77, Q5RE88, Q5T0N1, Q5XIZ9, Q61586, Q62240, Q63713, Q69ZN7, Q6DCF6, Q6P5U7, Q6PA97, Q86VS3, Q86YR7, Q8BWR4
Diamond homologs: A0JJX5, A1CQG2, A1ZBD6, A2QQ28, A3KGK3, A4IFJ5, A6QQP7, A8KBH6, B1WAZ6, B8N7E5, G0S9J5, O14065, O14795, O43581, O75131, O75923, O94812, P04409, P05126, P05128, P05129, P05696, P05771, P05772, P0C869, P0C871, P10102, P10829, P13677, P17252, P20444, P21521, P27715, P29101, P41823, P41885, P46097, P46935, P49147, P63318
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
287 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 231 |
| Likely benign | 19 |
| Benign | 11 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
6395 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:123963277:GATA:G | acceptor_gain | 1.0000 |
| 8:123966261:G:GT | donor_gain | 1.0000 |
| 8:123966286:ATGAA:A | donor_gain | 1.0000 |
| 8:123966287:TGAA:T | donor_gain | 1.0000 |
| 8:123966288:G:GT | donor_gain | 1.0000 |
| 8:123966288:GAA:G | donor_gain | 1.0000 |
| 8:123966290:AG:A | donor_loss | 1.0000 |
| 8:123966291:G:GG | donor_gain | 1.0000 |
| 8:123966291:GT:G | donor_loss | 1.0000 |
| 8:123966292:T:G | donor_loss | 1.0000 |
| 8:123970033:A:AG | acceptor_gain | 1.0000 |
| 8:123970034:G:GG | acceptor_gain | 1.0000 |
| 8:123973428:CCTCA:C | acceptor_loss | 1.0000 |
| 8:123973429:CTCA:C | acceptor_loss | 1.0000 |
| 8:123973430:TCA:T | acceptor_loss | 1.0000 |
| 8:123973431:CAG:C | acceptor_loss | 1.0000 |
| 8:123973432:A:AT | acceptor_loss | 1.0000 |
| 8:123973509:CCTGG:C | donor_loss | 1.0000 |
| 8:123973513:G:GC | donor_loss | 1.0000 |
| 8:123973514:T:TC | donor_loss | 1.0000 |
| 8:123975302:GAAAA:G | donor_gain | 1.0000 |
| 8:123975307:G:GG | donor_gain | 1.0000 |
| 8:123975390:G:A | acceptor_gain | 1.0000 |
| 8:123976031:GAC:G | donor_gain | 1.0000 |
| 8:123976032:ACA:A | donor_gain | 1.0000 |
| 8:123976035:G:GG | donor_gain | 1.0000 |
| 8:123977415:AG:A | acceptor_gain | 1.0000 |
| 8:123977416:GG:G | acceptor_gain | 1.0000 |
| 8:123977416:GGGGC:G | acceptor_gain | 1.0000 |
| 8:123977606:AAAGG:A | donor_loss | 1.0000 |
AlphaMissense
12337 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 8:124101176:T:A | W1655R | 1.000 |
| 8:124101176:T:C | W1655R | 1.000 |
| 8:124118856:G:C | A1768P | 1.000 |
| 8:123977456:T:A | W304R | 0.999 |
| 8:123977456:T:C | W304R | 0.999 |
| 8:124045794:T:A | W873R | 0.999 |
| 8:124045794:T:C | W873R | 0.999 |
| 8:124066512:T:A | W1214R | 0.999 |
| 8:124066512:T:C | W1214R | 0.999 |
| 8:124097793:T:C | L1598S | 0.999 |
| 8:124097812:C:A | N1604K | 0.999 |
| 8:124097812:C:G | N1604K | 0.999 |
| 8:124101180:G:C | R1656P | 0.999 |
| 8:124101294:T:C | L1694P | 0.999 |
| 8:124101302:T:A | W1697R | 0.999 |
| 8:124101302:T:C | W1697R | 0.999 |
| 8:124103251:T:A | I1744K | 0.999 |
| 8:124103277:T:A | W1753R | 0.999 |
| 8:124103277:T:C | W1753R | 0.999 |
| 8:124103280:T:A | W1754R | 0.999 |
| 8:124103280:T:C | W1754R | 0.999 |
| 8:124118851:T:A | V1766D | 0.999 |
| 8:124118857:C:A | A1768D | 0.999 |
| 8:124118863:T:C | F1770S | 0.999 |
| 8:124118869:T:C | L1772P | 0.999 |
| 8:124039969:C:A | A851D | 0.998 |
| 8:124045796:G:C | W873C | 0.998 |
| 8:124045796:G:T | W873C | 0.998 |
| 8:124049731:T:C | L950P | 0.998 |
| 8:124049749:T:C | L956P | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000014015 (8:124055176 C>A,T), RS1000025475 (8:123870874 T>C), RS1000027589 (8:123918943 C>A), RS1000036697 (8:124001687 G>C), RS1000044054 (8:124006360 G>T), RS1000058137 (8:123871149 A>C), RS1000062850 (8:124017879 T>C,G), RS1000065553 (8:124062335 T>C), RS1000070603 (8:123994989 T>C), RS1000071451 (8:124106601 A>T), RS1000084676 (8:124044100 T>C), RS1000090096 (8:124002009 G>A), RS1000093575 (8:124017608 T>C), RS1000102057 (8:124106447 G>A), RS1000116970 (8:123974949 A>G)
Disease associations
OMIM: gene MIM:620884 | disease phenotypes:
GenCC curated gene-disease
Mondo (1): congenital portosystemic shunt (MONDO:0018811)
Orphanet (1): Congenital portosystemic shunt (Orphanet:480531)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation, increases expression | 2 |
| Benzo(a)pyrene | affects methylation, decreases expression, increases methylation | 2 |
| Smoke | decreases expression, increases expression | 2 |
| Tobacco Smoke Pollution | affects expression, increases expression | 2 |
| methyleugenol | decreases expression | 1 |
| propionaldehyde | decreases expression | 1 |
| 2,5,2’,5’-tetrachlorobiphenyl | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| 2,6-dichloro-(1,4)benzoquinone | increases expression | 1 |
| Cadmium | decreases expression | 1 |
| N-Nitrosopyrrolidine | decreases expression | 1 |
| Phthalic Acids | decreases methylation | 1 |
| 8-Bromo Cyclic Adenosine Monophosphate | increases expression | 1 |
| Aflatoxin B1 | affects methylation | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
2 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT06041906 | Not specified | ENROLLING_BY_INVITATION | International Registry of Congenital Portosystemic Shunt (IRCPSS) |
| NCT07314814 | Not specified | NOT_YET_RECRUITING | Genetic Hallmarks of Patients With Congenital Portosystemic Shunts and Portopulmonary Hypertension |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): congenital portosystemic shunt